# FDA 483 - L'Oreal USA Products Inc - December 04, 2012

Source: https://www.globalkeysolutions.net/records/483/loreal-usa-products-inc/f3fce4d8-c98d-487b-8b0f-2ad6ef280ee2

> FDA 483 for L'Oreal USA Products Inc on December 04, 2012. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: L'Oreal USA Products Inc
- Inspection Date: 2012-12-04
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: L'Oreal USA Products Inc, an OTC drug product manufacturer in Somerset, NJ, was inspected by the FDA and cited for a significant quality control issue. The firm failed to thoroughly review unexplained discrepancies, specifically concerning multiple preservative system failures in various OTC SPF products. This included not consistently identifying specific root causes or implementing systemic corrective actions for these recurring problems.

## Related Documents

- [483 - 2024-02-15](https://www.globalkeysolutions.net/records/483/loreal-usa-products-inc/c0c250ef-330c-4de9-83bb-35c7478f8627)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/maria-estrella/36cf1d7d-41af-4f40-9de4-174a82a31a56)

Company: https://www.globalkeysolutions.net/companies/loreal-usa-products-inc/33ada4a1-f786-4ea0-aba2-4e25302c5cb9

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248